Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant925 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003939 | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 132 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Sep 24, 2012 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 |
| clinicaltrials |
| NCT00022620 | Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00052312 | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer | completed | Phase 2 | 141 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00316706 | Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine | completed | Phase 3 | 1,245 | GlaxoSmithKlineINDUSTRY | 5 | Sep 18, 2012 | clinicaltrials |
| NCT00496080 | Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding(DUAO) | terminated | N/A | 87 | Ethicon, Inc.INDUSTRY | 3 | Sep 10, 2012 | clinicaltrials |
| NCT00392769 | Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer | completed | Phase 2 | 33 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01029990 | Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Program | completed | Early Phase 1 | 8,800 | Göteborg UniversityOTHER | 0 | Aug 30, 2012 | clinicaltrials |
| NCT01328028 | Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand | completed | — | 244 | GlaxoSmithKlineINDUSTRY | 0 | Aug 27, 2012 | clinicaltrials |
| NCT01267461 | Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells | available | — | — | Meir Medical CenterOTHER | 0 | Aug 10, 2012 | clinicaltrials |
| NCT00084903 | Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears | completed | N/A | 1,070 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 2, 2012 | clinicaltrials |
| NCT00386217 | Psychosocial Impact of Cancer-Related Female Infertility | completed | — | 239 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00505726 | Reflectance Confocal Imaging in Cervical Cancer Patients | completed | — | 39 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 1, 2012 | clinicaltrials |
| NCT00511615 | Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia | completed | — | 30 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 1, 2012 | clinicaltrials |
| NCT00511758 | Digital Imaging Aid for Assessment of Cervical Dysplasia | terminated | — | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00513123 | Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia | completed | — | 100 | M.D. Anderson Cancer CenterOTHER | 3 | Aug 1, 2012 | clinicaltrials |
| NCT01045187 | Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer | completed | N/A | 15 | Xoft, Inc.INDUSTRY | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00334295 | Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma. | completed | Phase 2 | 35 | AstraZenecaINDUSTRY | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00505739 | Mifepristone for Patients With Endometrial Cancer and LGESS | completed | Phase 2 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00750672 | Follow-up Care After Treatment for Endometrial Cancer | completed | — | 20 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | completed | Phase 3 | 340 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00003209 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | completed | Phase 3 | 700 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00003267 | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer | completed | Phase 3 | 214 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Jul 11, 2012 | clinicaltrials |
| NCT00267488 | Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Jul 11, 2012 | clinicaltrials |
| NCT00628901 | A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | completed | Phase 4 | 60 | Boston Scientific CorporationINDUSTRY | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00002916 | Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 2, 2012 | clinicaltrials |
| NCT01290406 | BEZ235 Trial in Patients With Advanced Endometrial Carcinoma | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 12 | Jun 21, 2012 | clinicaltrials |
| NCT00003127 | S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer | completed | Phase 2 | 57 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00003369 | S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer | completed | Phase 2 | 56 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00057928 | S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer | withdrawn | Phase 3 | 0 | SWOG Cancer Research NetworkNETWORK | 2 | Jun 13, 2012 | clinicaltrials |
| NCT01313104 | Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer | withdrawn | N/A | 0 | Northwestern UniversityOTHER | 0 | Jun 11, 2012 | clinicaltrials |
| NCT00773071 | Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers | completed | N/A | 15 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00003669 | Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00004915 | Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00032162 | Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer | completed | Phase 1 / Phase 2 | 63 | AGO Study GroupOTHER | 1 | May 31, 2012 | clinicaltrials |
| NCT00872937 | Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions | unknown | — | 800 | National Taiwan University HospitalOTHER | 1 | May 17, 2012 | clinicaltrials |
| NCT00004866 | DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT01594879 | Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer | unknown | Phase 2 | 39 | Korean Gynecologic Oncology GroupOTHER | 1 | May 9, 2012 | clinicaltrials |
| NCT01594099 | Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women | unknown | Phase 2 | 45 | Xi'an Jiaotong UniversityOTHER | 0 | May 8, 2012 | clinicaltrials |
| NCT01221987 | Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer | completed | — | 40 | GlaxoSmithKlineINDUSTRY | 0 | Apr 30, 2012 | clinicaltrials |
| NCT00430144 | Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix | completed | Phase 2 | 16 | Sokbom KangOTHER_GOV | 1 | Apr 26, 2012 | clinicaltrials |
| NCT01584414 | Evaluation of the Zetiq Histological and Cytological Staining Technique for the Detection Cervical Cancer | completed | — | 210 | Meir Medical CenterOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT00231829 | A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | terminated | Phase 2 | 23 | Mark H. EinsteinOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00231855 | Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers | completed | Phase 2 | 31 | Montefiore Medical CenterOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00333086 | A Study of Letrozole in the Treatment of Endometrial Cancer | completed | Phase 2 | 36 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00982631 | A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer | unknown | Phase 1 | 30 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT01560026 | Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma(ECWOP) | unknown | — | 300 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00500435 | Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer | completed | — | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01561326 | Facilitating Follow-Up Adherence for Abnormal Pap Smears(TC3) | completed | N/A | 211 | Fox Chase Cancer CenterOTHER | 1 | Mar 23, 2012 | clinicaltrials |
| NCT01418859 | Clinical Study in Post-operation Treatment of Cervical Cancer | unknown | — | 183 | Xi'an Jiaotong UniversityOTHER | 1 | Mar 21, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Sep 24, 2012source: clinicaltrials